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There has been long-standing concern about 
the health consequences of indoor exposure to 
gas combustion products (e.g., Garrett et al. 
1998; Jarvis et al. 1996, 1998; Kerkhof et al. 
1999; Melia et al. 1979; Ng et al. 2001; Phoa 
et al. 2004; Pilotto et al. 1997; Ponsonby 
et al. 2001a; Wong et al. 2004). Most con-
cern has focused on the respiratory effects of 
emissions of oxides of nitrogen, particularly 
nitrogen dioxide (NO2) (Bauer et al. 1986; 
Chauhan et al. 2003; Tunnicliffe et al. 1994), 
although not all studies have demonstrated 
adverse effects at the observed concentrations 
(Salome et al. 1996; Samet et al. 1993).
There have been two randomized con-
trolled trials that contribute a higher level of 
evidence. One of these is a parallel-group, 
randomized, controlled trial of a home-
  heating intervention conducted in a cohort of 
New Zealand houses that were poorly heated, 
including 55% with unflued gas heaters and 
others with electric or other heating sources, 
and in which at least one child had asthma 
(Howden-Chapman et al. 2008). Children 
whose homes were insulated and fitted with 
an effective nonpolluting heater had less noc-
turnal cough and wheeze, fewer lower respira-
tory tract symptoms, and better self-assessed 
health status during winter than those in the 
control group who did not receive any inter-
vention until the study was over. There was 
no difference in lung function. This study 
demonstrated an improvement in clinically 
relevant health outcomes attributable to this 
home modification intervention. However, it 
is not clear whether the change was due to the 
nature of the fuel source or the effectiveness 
of the heating. Although the active group had 
substantially lower NO2 concentrations in 
the living room (8.5 µg/m3 vs. 15.7 µg/m3, 
p < 0.001) and in the child’s bedroom (means 
7.3 µg/m3 vs. 10.9 µg/m3, p < 0.001) than 
the control group, there was also a 0.57°C 
higher average temperature in the child’s bed-
room and a 50% reduction in the proportion 
of nights in which the temperature fell below 
10°C in the active intervention houses. One 
limitation of the study was the absence of 
any blinding, which would not have been 
feasible in a parallel-group study. Because the 
outcomes that changed were all subjective, 
this possible source of reporting bias needs to 
be considered. However, despite these limita-
tions, this study does strongly support the 
conclusion that there will be health benefits 
for children with asthma from the use of non-
polluting, effective domestic heating sources 
in cold climates.
The other randomized controlled trial was 
conducted in Australian schools (Pilotto et al. 
2004). It was also a parallel-group, random-
ized, controlled trial in which there was no 
attempt to blind participants in the active 
intervention group that they were receiving 
new heaters. The control classrooms were 
heated with unflued heaters. Among children 
with asthma in the randomized classrooms, 
those in the active intervention classrooms 
were less likely to report difficulty in breath-
ing (during the day or night), chest tightness 
(during the day), and asthma attacks during 
the day. There was no difference in lung func-
tion or airway hyperresponsiveness. As with 
the New Zealand study, the parallel-group 
design, which did not allow blinding, leaves 
some concern about possible reporting bias 
for subjective outcomes.
In New South Wales (NSW), unflued 
gas heaters have been the principal form of 
heating used in schools for many years. In 
response to emerging concerns in the late 
1980s, the NSW Department of Education 
embarked on program of replacing its existing 
older-style unflued gas heaters with a newly 
designed low-NOx (nitrogen oxides) unflued 
gas heater (Bowin Lo-NOx; Bowin mfg Pty 
Ltd, Sydney, Australia) (McPhail et al. 1989). 
These are designed to conform to a 2-ng NO2 
per J standard (Bowin mfg Pty Ltd). However, 
there are continuing concerns about potential 
hazards arising from these heaters.
There has been one published report of a 
laboratory-based assessment of emissions from 
low-NOx unflued gas heaters (Brown et al. 
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Ba c k g r o u n d: There are long-standing concerns about adverse effects of gas appliances on   respiratory 
health. However, the potential adverse effect of low-NOx (nitrogen oxide) unflued gas heaters on 
children’s health has not been assessed.
oBjectives: Our goal was to compare the respiratory health effects and air quality consequences of 
exposure to low-NOx unflued gas heaters with exposure to non–indoor-air-emitting flued gas heat-
ers in school classrooms.
Me t h o d s : We conducted a double-blind, cluster-randomized, crossover study in 400 primary 
school students attending 22 schools in New South Wales, Australia. Children measured their lung 
function and recorded symptoms and medication use twice daily. Nitrogen dioxide (NO2) and 
formaldehyde concentrations were measured in classrooms using passive diffusion badges.
re s u l t s: NO2 concentrations were, on average, 1.8 times higher [95% confidence interval (CI), 
1.6–2.1] and formaldehyde concentrations were, on average, 9.4 ppb higher (95% CI, 5.7–13.1) dur-
ing exposure to unflued gas versus flued gas heaters. Exposure to the unflued gas heaters was associ-
ated with increased cough reported in the evening [odds ratio (OR) = 1.16; 95% CI, 1.01–1.34] and 
wheeze reported in the morning (OR = 1.38; 95% CI, 1.04–1.83). The association with wheeze was 
greater in atopic subjects. There was no evidence of an adverse effect on lung function.
co n c l u s i o n s: We conclude that classroom exposure to low-NOx unflued gas heaters causes 
increased respiratory symptoms, particularly in atopic children, but is not associated with significant 
decrements in lung function. It is important to seek alternative sources of heating that do not have 
adverse effects on health.
key w o r d s : children, nitrogen dioxide, randomized controlled trial, respiratory health effects, 
schools. Environ Health Perspect 118:1476–1482 (2010).  doi:10.1289/ehp.1002186 [Online 
27 July 2010]Health effects of low-NOx unflued gas heaters
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2004). This study showed that the five tested 
heaters did emit NO2 and, in some cases, 
formaldehyde and carbon monoxide. However, 
because no old-style heaters were tested using 
the same protocol, this study did not allow 
assessment of the extent to which these low-
NOx heaters were qualitatively or quantita-
tively different, as claimed, from the older-style 
heaters. Hence, it is difficult to know whether 
this study validates the application of health 
data from the clinical studies conducted with 
the older-style heaters to the low-NOx heaters.
In summary, there are real health concerns 
about indoor exposure to combustion products 
from unflued gas heaters. Two randomized 
control trials suggest that benefits may follow 
from replacement of these unflued gas heat-
ers, but the design of these trials imposes some 
limitations on interpretation. Furthermore, the 
previous Australian trial included both older-
style and low-NOx gas heaters in the control 
group (Pilotto L, personal communication), 
and only very limited data are available about 
potential adverse effects of these newer type of 
gas heaters. Hence, we conducted a random-
ized, double-blind, crossover study comparing 
the respiratory health effects and air quality 
consequences of exposure to newer-style low-
NOx gas heaters with exposure to non–indoor-
air-emitting flued gas heaters.
Methods
The study was a three-period, cluster-
  randomized, controlled, crossover study 
conducted in primary school classes. Two con-
ditions were compared: heating with a low-
NOx unflued gas heater and heating with a 
flued gas heater. Classrooms were fitted with 
both types of heaters. In each classroom the 
existing low-NOx unflued gas heater was left 
in situ, and the flued gas heater was installed 
co-located with it in the classroom. Both heat-
ers were surrounded with a screen so that those 
in the room would not be able to see which 
one was operating. During the study period 
either the low-NOx unflued gas heater or the 
flued gas heater was in active mode for 1-week 
periods. The 6-week study period was arranged 
in three consecutive pairs of 2 weeks. For 
each classroom, the order of operation of the 
unflued and flued gas heaters was randomized 
separately for each pair of weeks. Hence, each 
classroom used a low-NOx unflued gas heater 
for three 1-week periods and a flued gas heater 
for three 1-week periods. During this time 
the heaters were operated at the discretion of 
the class teacher, in the usual way, accord-
ing to heating need. Further details about the 
installation and control of heaters, blinding of 
participants, and the randomization procedure 
are provided in the Supplemental Material 
(doi:10.1289/ehp.1002186).
The study was conducted in schools in the 
Blue Mountains, Southern Highlands, and 
Goulburn regions of NSW. These are elevated 
areas outside the Sydney metropolitan area. 
They were chosen because of their relatively 
cold climate and proximity to Sydney. Baseline 
assessments were conducted in June 2009, a 
run-in and pilot-testing week was conducted 
beginning 3 August 2009, and the 6-week 
study period began on 10 August 2009. The 
pilot-testing week was 1 week after the 2-week 
mid-winter break. August is the last month of 
winter in the southern hemisphere.
The trial was approved by the Human 
Research Ethics Committee of the University 
of Sydney and the NSW Department of 
Education and Training State Education 
Research Approvals Process. Parents gave 
written informed consent prior to par-
ticipation of their child in the research. 
The trial was registered with the Australian 
and New Zealand Clinical Trials registry 
(ACTRN12609000610235; 22 July 2009).
Study population. There was a two-stage 
selection process in which schools and class-
rooms were selected and then participants 
within the selected classrooms were recruited. 
Eligibility criteria for classrooms were that 
they were fitted with existing unflued gas heat-
ers, that it was feasible to install a flued gas 
heater, and that the class using the selected 
room included 20 students in grades 4, 5, or 6. 
Principals of 38 schools in the Blue Mountains, 
Southern Highlands, and Goulburn regions 
were invited to nominate classes to partici-
pate. All students in the selected classrooms 
were eligible for inclusion in the study. Those 
whose parents gave written informed consent 
were recruited.
Monitoring heater use. Temperature moni-
tors (HOBO H8 series data loggers; Onset, 
Pocasset, MA, USA) were installed in the 
enclosures to estimate the running times for 
each heater. Abrupt changes in temperature 
were used to identify the times when heaters 
were turned on or off. These temperature log-
gers began operating only from the third study 
week (24 August 2009).
In-class temperature was also recorded at 
2-min intervals between 0900 and 1500 hours 
on each study day.
Respiratory health assessments. We col-
lected baseline information on respiratory 
symptoms and illnesses and use of gas and 
other heaters at home using a questionnaire 
completed by the parents. We also measured 
spirometric lung function before and after 
administration of 200 µg albuterol via spacer. 
Current asthma was defined as reported 
wheeze in the preceding 12 months and either 
a reported doctor’s diagnosis of asthma or 
an increase in forced expiratory volume in 
1 sec (FEV1) after albuterol that was ≥ 12% 
of baseline. Height and weight were meas-
ured using a stadiometer and portable scales, 
respectively.
We measured atopy by using skin prick 
tests to inhalant allergens Dermatophagoides 
pteronyssinus (HDM), Dermatophagoides farina 
(also HDM), cockroach, cat, Alternaria, 
Aspergillus, rye grass, and a grass mix (Hollister-
Stier, Spokane, WA, USA), as previously 
described (Peat et al. 2004). Glycerol and 
histamine phosphate 10 mg/mL were used as 
negative and positive controls, respectively. 
Wheal sizes were measured 15 min later and 
those that were ≥ 3 mm and were also greater 
than negative control were classified as positive. 
Subjects with positive reactions to any allergen 
were classified as atopic.
The main study outcomes were symptoms 
and lung function measurements recorded 
twice daily by participants. Children kept a 
daily symptom and medication diary for the 
6-week study period. Subjects were asked to 
record each morning the presence of cough 
and wheeze or chest tightness during sleep. 
They were asked to record each evening the 
presence of cough, wheeze or chest tightness, 
fever, sore throat, runny or blocked nose, eye 
irritation, sore teeth or gums, and stomach-
ache during the day. The last two questions 
were included to detect possible information 
bias. For each symptom subjects were asked 
to indicate whether they had “no symptoms 
during the day” (scored 0), “symptoms, but 
did not disturb your daily activities” (score 1), 
“symptoms that disturbed part of your daily 
activities” (score 2), or “symptoms that dis-
turbed the whole day or most of your daily 
activities” (scored 3). Subjects also recorded 
whether they used bronchodilator (reliever) 
medication twice a day and, if so, whether it 
was for relief of symptoms or as part of their 
regular medication regimen. In the evening 
subjects also recorded if they had taken preven-
ter medications for asthma, been exposed to 
an unflued gas heater or other type of heater at 
home, and/or been exposed to environmental 
tobacco smoke (ETS) during that day.
We used Mini-Wright Digital (MWD) 
portable electronic spirometers (Clement 
Clarke, Harlow, Essex, UK) to record lung 
function twice daily. Children were instructed 
to perform three forced expiratory maneuvers 
into their MWD devices in the morning and 
in the evening. The device records only the 
highest FEV1 and peak expiratory flow rate 
(PEF) from the attempts made during any 
session. Each recording is made with an asso-
ciated date and time stamp. Detailed instruc-
tions on how to do this were included on the 
reverse side of the diary card.
Each week the diaries were collected, and 
MWD data were downloaded during the 
school visits. The parents were sent a text mes-
sage (SMS) the day before the teams were in 
the schools to remind the children to bring the 
diaries to the schools the next day. After the 
diaries were collected they were checked for Marks et al.
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errors and missing information. Families were 
then telephoned to attempt to correct the mis-
takes or to fill in the missing information.
Once each week, on Thursday or Friday, 
we recorded PEF and FEV1 using the child’s 
own MWD device. This served as an in-
school measurement of lung function and also 
provided an opportunity to check their tech-
nique and correct it if needed. In addition at 
these school visits, we also recorded exhaled 
nitric oxide (eNO), using the offline method 
(Salome et al. 1999).
Measurement of indoor NO2 and formal-
dehyde concentrations. Airborne NO2 concen-
trations in school classrooms were measured 
using passive diffusion badge monitors sup-
plied by the CSIRO Division of Atmospheric 
Research; Clayton South, Victoria, Australia). 
Formaldehyde samples were collected using 
UMEx 100 (SKC Inc., Eighty Four, PA, 
USA) passive sampling badges.
On Thursday and Friday of every week 
during the study period, two NO2 samplers 
were exposed at two different locations in 
each classroom. One formaldehyde sampler 
was co-located at one of these sites on both 
occasions. Further details about the placement 
of the samplers and their chemical analysis 
are provided in the Supplemental Material 
(doi:10.1289/ehp.1002186).
Study power and sample size estimates. On 
the basis of previous data from our research 
group, we estimated that the within-subject 
SD in FEV1 was 200 mL. On this basis, using 
a simple crossover paired t-test analysis, 43 
subjects would be sufficient to give 90% power 
to detect difference in FEV1 between the two 
exposures of ≥ 100 mL. We expected to have 
an average of 15 student participants in each 
class. If the intraclass correlation coefficient for 
classrooms was as high as 0.2, then the design 
effect would be 3.8 and the required sample 
size increased to 164 subjects in 11 classrooms. 
To contend with potential nonparticipation 
and dropout among subjects and to facilitate 
the subgroup analyses proposed in the second 
hypothesis, we intended to recruit an average 
of 20 students from each of 20 classrooms, for 
a total of 400 children.
Statistical analysis. Analysis was con-
ducted in SAS 9.2 (SAS Institute Inc., Cary, 
NC, USA). A p-value (alpha) < 0.05 was 
regarded as statistically significant.
A mean morning symptom score and 
a mean evening symptom score (excluding 
“sore teeth or gums” and “stomachache”) was 
calculated for each subject for each day. PEF 
and FEV1 recordings made between midnight 
and 1200 hours were designated as morning 
values, and those made between 1200 hours 
and midnight were designated as evening val-
ues. We limited the data analyzed to those 
relevant to a period within 24 hr after the 
last exposure to heaters in schools. Hence, 
analyses of morning symptoms and lung 
function data excluded observations made on 
Sunday and Monday mornings, and analyses 
of evening reports of symptoms and records 
of lung function excluded observations made 
on Saturday and Sunday evenings.
The effect of randomized heater type allo-
cation (that is, exposure to flued vs. unflued 
gas heaters) was estimated using hierarchi-
cal or mixed-model regression. Fixed effects 
were the heater type allocation, study period 
(first, second, or third pair of weeks), and 
day of the week. In a preliminary analysis 
we also included heater type randomization 
order (that is, flued heater in the first week of 
a pair vs. unflued heater in the first week of a 
pair) and the heater type by heater type order 
interaction to test for order effects. Subjects 
were included as random intercept assuming 
an unstructured (variance components) cor-
relation matrix for the outcomes measured 
on individuals (diary card and lung function 
outcomes). Mixed models treat missing values 
as missing at random, which is a less-rigorous 
assumption than missing completely at ran-
dom. School was included as either a random 
effect or a fixed effect, as described below.
In a planned subsidiary analysis, we tested 
for current asthma status by heater type and 
atopic status by heater type interactions; 
where these interactions were significant, we 
fitted separately the models described above 
for the subgroup with current asthma or the 
subgroup with atopy.
The primary analysis used all data in an 
intention-to-treat (ITT) analysis. However, 
we also fitted a per-protocol model in which 
the analysis was limited to schools and days 
for which heater use was estimated as ≥ 30%. 
We also tested the effect of three time-variable 
confounders—use of gas heaters at home, use 
of an open fire at home, and exposure to ETS 
at home—on the effect of the randomized 
Table 1. Baseline characteristics of the study 
population that completed at least one diary card.
Characteristic
na (%) or 
mean ± SD
Total subjects with diary cards 400 (100)
Females 220 (55)
Atopicb
Yes 152 (44)
No 192 (56)
Missing 56
Wheeze ever 168 (42)
Wheeze in the last 12 months 84 (21)
Doctor-diagnosed asthma 108 (27)
Positive bronchodilator testc
Yes 39 (10)
No 337 (90)
Missing 24
Current asthmad 60 (15)
Use of any medicines for asthma 81 (21)
Smoking inside the house 28 (7)
Gas heating at homee
Flued 66 (17) 
[9 missing]
Unflued 89 (23) 
[11 missing]
Gas for cooking at home 202 (51)
Age (years) 10.6 ± 0.9
Height (cm) 143.7 ± 8.8 
[10 missing]
Weight (kg) 39.8 ± 10.4 
[10 missing]
FEV1 (L) 2.02 ± 0.39 
[12 missing]
FEV1 (% predicted) 90.8 ± 10.2 
[16 missing]
Forced vital capacity (L) 2.39 ± 0.47 
[12 missing]
Forced vital capacity (% predicted) 94.6 ± 10.5 
[16 missing]
eNO (ppb)f 8.04 (2.3–27.7) 
[56 missing]
aComplete data or missing four or fewer subjects unless 
otherwise indicated. bSensitized to one or more of the 
test allergens. cIncrease in FEV1 after bronchodilator 
≥ 12% of baseline value. dCurrent asthma defined as 
wheeze in the last 12 months and either doctor-diag-
nosed asthma or a positive bronchodilator test. eSubjects 
who indicated they had no heating or had another type 
of heating at home but who did not answer the ques-
tion about gas heating were assumed not to have a 
gas heater. Subjects who had a flued gas heater were 
assumed not to have an unflued gas heater. fGeometric 
mean and geometric 95% range are shown.
Table 2. Concentrations of NO2 and formaldehyde measured by badges, by treatment group.
Overall Flued Unflued
Gas (ppb) Mean 95% Geometric range Mean 95% Geometric range Mean 95% Geometric range
NO2
a 23.5 4.6–121.4 17.5 3.5–88.4 31.6 7.4–135.2
Formaldehyde 28.6 1.8–55.4 24.7 3.3–46.1 32.6 3.1–62.1
aValues for NO2 are geometric mean and geometric 95% range. 
Table 3. Effect of heater type on NO2 and formaldehyde levels, measured by badges.
NO2  
(relative difference: unflued/flued)
Formaldehyde (absolute difference:  
unflued – flued ppb)
Population n Mean ratio 95% CI p-Value n Mean difference 95% CI p-Value
ITT analysisa 248 1.80 1.55–2.10 < 0.0001 167 9.6 5.9–13.3 < 0.0001
Per protocolb (weeks when 
heater use is ≥ 30%)
51 2.33 1.53–3.55 0.0002 44 20.1 10.6–29.6 0.0001
The ratios and differences and their 95% CIs are derived from a mixed-model regression. Fixed effects were the heater 
type allocation, study period (first, second, or third pair of weeks), and day of the week. Schools were treated as random 
intercept, and a variance components correlation structure was assumed. 
aAll observations are analyzed according to the heater type exposure to which they were assigned. bThe analysis was 
limited to schools and days for which heater use was estimated as ≥ 30%.Health effects of low-NOx unflued gas heaters
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heater–type exposure on symptoms. Each of 
these three confounding factors was measured 
daily using the diary.
For normally distributed continuous out-
comes (FEV1, PEF, exhaled NO, and in-class 
formaldehyde), we used Proc Mixed (version 
9.2; SAS Institute Inc., Cary, NC, USA) to fit 
the model assuming a normal error distribu-
tion. School was included as an additional ran-
dom-intercept term in these models. We used 
a similar model for the log10-transformed val-
ues of in-class NO2 concentrations. The effect 
of heater type on the outcome was estimated 
as a difference with its 95% confidence inter-
val (CI). The difference in log-transformed 
NO2 concentrations was raised to the power 
of 10 (anti-logged) to yield a ratio.
Symptoms were treated as both a binary 
variable (present or absent) and a continu-
ous score variable (0–3) and analyzed using 
Proc GLIMMIX with the Laplace estimation 
routine (SAS Institute Inc.). For binary out-
comes, we used a logistic link and binary error 
structure and estimated odds ratios (ORs). 
For score variables, we used a log link and 
Poisson error structure. In some cases it was 
not possible to fit the model when school 
was included as a second random intercept. 
Therefore, for all logistic and Poisson models, 
school was included as an additional fixed 
effect rather than a random effect.
Results
Study participants. Twenty-two schools par-
ticipated in the project. Overall, 418 subjects 
participated in at least one part of the study, 
representing 77% of the 543 students in the 
selected classes. Three students did not submit 
a baseline questionnaire. At least one diary 
was received for 400 participants (74% of eli-
gible students). These participants formed the 
study population. In any given week, average 
participation rates ranged from 64% to 73%.
Slightly over half the participants were 
girls, and their mean age was 10.6 years 
(Table 1). Nearly half were atopic, including 
34% who were sensitized to house dust mite 
allergen. Approximately 15% had current 
asthma, but 21% were using some asthma-
related medication. Unflued gas heaters were 
used in nearly one quarter of all participants’ 
homes and half used gas for cooking.
Use of heaters in schools. Heater use was 
monitored during weeks 3–6 and was quantified 
as the proportion of time between 0900 and 
1500 hours that the heaters were in operation. 
Across the 22 schools, median (interquartile 
range) daily heater use during weeks 3–6 was 
25.7% (0–47.2%), 30.4% (6.9–47.8%), 16.7% 
(0–41.7%), and 0% (0–9.7%) of the school 
day, respectively. Heater use was recorded as 
≥ 30% on 157 school days.
Mean daily in-class temperature between 
0900 and 1500 hours was 20.9°C on days 
when the unflued gas heater was operating 
and 20.5°C on days when the flued gas heater 
was operating (difference adjusted for random 
effects 0.4°C; 95% CI, 0.0–0.8, p = 0.07). 
When the analysis was limited to days when the 
heaters were operating for at least 30% of the 
day, the mean temperatures were slightly higher 
during the period of operation of the unflued 
gas heater (19.6°C) than during the periods of 
operation of the flued gas heater (18.6°C). The 
mean difference was 1.0°C (95% CI, 0.5–1.5).
Effect of heater type on NO2 and formal-
dehyde concentrations in the classroom. The 
overall geometric mean NO2 concentration in 
classrooms was 32 ppb (60.2 µg/m3), and the 
overall mean concentration of formaldehyde 
was 29 ppb (35.6 µg/m3) during school hours 
on the days of measurement.
There was a significant order by heater 
type interaction in the effect on NO2 concen-
trations (p = 0.01). However, as both order 
sequences showed an increase in NO2 levels 
when the unflued gas heater was operating, 
order effects were not considered further. The 
order by heater type interaction was not sig-
nificant for formaldehyde.
There were highly significant effects of 
heater type on concentrations of NO2 and 
formaldehyde in the classrooms (Tables 2 and 
3). The effect was larger in magnitude when 
the analysis was limited to weeks and class-
rooms in which heaters were used for ≥ 30% 
of the time.
Estimated effects of heater type on lung 
function and airway inflammation (eNO). 
The randomized order in which classrooms 
were exposed to the two types of heaters 
(unflued gas heaters and flued gas heaters) 
had no significant influence on the effects of 
the heater type on lung function or airway 
inflammation (p > 0.2 for all heater type by 
order interactions). However, the estimated 
effect of heater type on PEF measured in the 
evening differed between people with and 
without asthma (p = 0.01). Atopic status did 
not influence the effect of heater type on lung 
function or eNO concentrations (all p > 0.1).
In the ITT analysis for the whole study 
population, heater type did not have any 
significant effect on any of the lung func-
tion measures after adjustment for day of the 
week, study week, and clustering by subject 
and school (Table 4). However, when the 
analysis was limited to days and schools in 
which heater use was ≥ 30%, morning FEV1 
was 0.03 L (95% CI, 0.003–0.057, p = 0.03) 
higher during the period of exposure to the 
unflued gas heater. Similarly, in this sub-
group, evening PEF was 5.2 L/min (95% CI, 
1.0–9.3, p = 0.01) higher during operation 
of the unflued gas heater. Evening PEF was 
7.3 L/min (95% CI, 0.6–13.7) higher dur-
ing the operation of the unflued gas heater in 
the ITT analysis in the asthma subgroup but 
not in the nonasthma subgroup (difference 
= –0.1 L/min; 95% CI, –2.2 to 1.9). In the 
per-protocol analysis (when heater use was 
≥ 30%) for the asthma subgroup, the asso-
ciation of unflued gas heater exposure with 
higher evening PEF was similar but was not 
statistically significant.
Table 4. Effect of heater type (unflued gas heater – flued gas heater) on lung function.a
FEV1 morning (L) FEV1 evening (L) PEF morning (L/min) PEF evening (L/min)
Population Unflued Flued Diff 95% CI p-Value Unflued Flued Diff 95% CI p-Value Unflued Flued Diff 95% CI p-Value Unflued Flued Diff 95% CI p-Value
ITT analysisb 1.95 1.95 0.004 –0.009 to 
0.017
0.55 1.96 1.96 0.000 –0.014 to 
0.014
0.99 271 270 0.719 –1.239 to 
2.677
0.47 279 278 0.994 –0.995 to 
2.983
0.33
Per protocol: days 
with heater use 
≥ 30%c
1.91 1.88 0.030 0.003 to 
0.057
0.03 1.91 1.91 0.008 –0.021 to 
0.037
0.59 269 268 0.832 –3.505 to 
5.168
0.71 277 272 5.185 1.032 to 
9.338
0.01
Asthma subgroup, 
ITT analysisd
1.84 1.84 0.001 –0.038 to 
0.041
0.95 1.84 1.85 –0.017 –0.061 to 
0.027
0.45 253 250 2.285 –4.954 to 
9.524
0.54 260 253 7.130 0.578 to 
13.682
0.03
Asthma subgroup, 
per-protocol 
analysise
1.84 1.79 0.056 –0.027 to 
0.139
0.19 1.74 1.80 –0.059 –0.174 to 
0.056
0.31 255 255 0.021 –11.637 to 
11.679
1.00 260 251 8.910 –7.543 to 
25.362
0.29
Diff, difference.
aThe means and differences and the 95% CIs for the differences are derived from mixed model regression. Fixed effects were the heater type allocation, study period (first, second, or third pair of 
weeks), and day of the week. Schools and subjects within schools were both treated as random intercepts, and a variance components correlation structure was assumed. bAll observations were 
analyzed according to the heater type exposure to which they were assigned. There were 6,776 observations for FEV1 morning and PEF morning and 6,504 observations for FEV1 evening and PEF 
evening cThe analysis was limited to schools and days for which heater use was estimated as ≥ 30%. There were 1,249 observations for FEV1 morning and PEF morning and 1,441 observations for 
FEV1 evening and PEF evening. dAll observations in subjects with current asthma at baseline were analyzed according to the heater type exposure to which they were assigned. There were 982 
observations for FEV1 morning and PEF morning and 987 observations for FEV1 evening and PEF evening. eThe analysis was limited to schools and days for which heater use was estimated as ≥ 30% 
in subjects with asthma. There were 169 observations for FEV1 morning and PEF morning and 213 observations for FEV1 evening and PEF evening.Marks et al.
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The findings on lung function were 
not substantially different when data were 
excluded for subject days on which the sub-
ject used a bronchodilator in the morning or 
the evening [Supplemental Material, Table E1 
(doi:10.1289/ehp.1002186)]. There was no 
evidence of any decrement in lung function 
attributable to unflued gas heater exposure 
when the analysis was restricted in this way.
Analysis of lung function measures 
recorded during in-school testing on Thursday 
or Friday of each study week revealed that 
the unflued gas heater was associated with 
a small increase in FEV1 [0.03 L (95% CI, 
0.01–0.05), p = 0.01] compared with the 
flued gas heater. The magnitude and direction 
of the estimated effect on FEV1 was similar 
in the per-protocol analysis [0.03 L (95% CI, 
–0.01 to 0.08), p = 0.14]. There were no sig-
nificant effects on PEF measured at the same 
time, although the trend was in the same 
direction (data not shown).
Overall, eNO levels, which were measured 
at the same time as the in-school lung function 
measurements, did not differ between periods 
of exposure to the two heater types in either 
the ITT or per-protocol analysis. However, 
there was a significant interaction with current 
asthma status in the per-  protocol analysis (p = 
0.002). In the subgroup with current asthma, 
eNO concentrations were 3.7 ppb higher dur-
ing exposure to the unflued gas heater than 
during exposure to the flued gas heater (95% 
CI, –0.5 to 7.9, p = 0.08). However, in the 
subgroup without asthma, the effect of flued 
versus unflued gas heater exposure on eNO 
concentrations was close to zero [0.03 ppb 
(95% CI, –0.68 to 0.74), p = 0.93].
Effect of heater type on respiratory symp-
toms. The overall daily prevalence of wheeze 
in the morning was 4.9% during periods of 
exposure to the low-NOx unflued gas heater 
and 4.4% during exposure to flued gas heater 
(Table 5). For wheeze reported in the eve-
ning, the overall prevalence was 5.7% and 
5.2% respectively. The prevalence of cough 
reported in the morning was 14.2% during 
both exposure periods, and the prevalence of 
cough reported in the evening was 21.6% and 
20.6%, respectively.
Treatment order did not influence the 
effect of heater type on symptoms except in 
relation to symptoms recorded in the eve-
ning (p = 0.02). However, no separate analy-
sis by treatment order was undertaken. The 
estimated effect of heater type on symptoms 
did not differ significantly by current asthma 
status, but did according to atopic status, par-
ticularly in relation to wheeze recorded in the 
morning (p = 0.0009) and in the evening (p = 
0.01) and the use of bronchodilators to relieve 
symptoms (p = 0.002).
In the ITT analysis, exposure to the 
unflued gas heater was associated with an 
increase in cough reported in the evening and 
wheeze reported in the morning (Table 6). 
When the analysis was restricted to days when 
heater use was ≥ 30%, the findings were gen-
erally similar, although no significant differ-
ences were found. After adjustment for use 
of unflued gas heaters or open fires at home 
and exposure to ETS at home, the associa-
tion of heater type with wheeze reported in 
morning was stronger (OR = 1.60; 95% CI, 
1.17–2.19, p = 0.003) than without adjust-
ment (OR = 1.38; 95% CI, 1.04–1.83, p = 
0.03). However, the association with cough 
reported in the evening was weaker and no 
longer significant after adjusting for these 
confounders.
The association with morning wheeze was 
evident in atopic subjects in the ITT analysis 
(OR = 1.85; 95% CI, 1.26–2.72, p = 0.002) 
and was particularly strong in this subgroup 
when the analysis was limited to days when 
heater use was ≥ 30% (OR = 7.72; 95% CI, 
1.55–38.43, p = 0.01). The evidence of an 
association with wheeze in atopic subjects was 
strengthened by the finding of an increased 
use of bronchodilators for relief of symptoms 
with exposure to the unflued gas heater in this 
subgroup (OR = 1.87; 95% CI, 1.08–3.25, 
p = 0.03). In the nonatopic subgroup, these 
adverse effects were not observed. In the ITT 
analysis in nonatopic subjects, there was no sig-
nificant association with wheeze reported in the 
morning (OR = 0.63; 95% CI, 0.39–1.02, p = 
0.06). There was a significant protective asso-
ciation with wheeze reported in the evening 
(OR = 0.50; 95% CI, 0.30–0.84, p = 0.009) 
and with the use of bronchodilator for relief of 
symptoms (OR = 0.45; 95% CI, 0.23–0.91, 
p = 0.03). The atopic subgroup was slightly less 
likely to report cough in the morning when 
exposed to the unflued gas heaters (OR = 0.77; 
95% CI, 0.60–0.98, p = 0.03).
There was no consistent evidence of an 
association between heater type and reporting 
of sore teeth or stomachache, although the lat-
ter was associated with exposure to unflued gas 
heaters in the atopic subgroup in the ITT analy-
sis (OR = 1.63; 95% CI, 1.06–2.49, p = 0.02).
The findings when symptoms were ana-
lyzed based on symptom scores (0–3) were 
broadly similar to those observed when symp-
toms were treated as simply present or absent 
(data not shown). The association between 
heater type and wheeze score differed signifi-
cantly between atopic and nonatopic subjects, 
with more adverse associations in the atopic 
Table 5. Prevalence of wheeze and cough by gas heater (flued or unflued) type and population subgroup.
Morning cough Evening cough Morning wheeze Evening wheeze
Population Flued  Unflued  Flued  Unflued  Flued  Unflued  Flued  Unflued 
ITT analysisa 14.2 14.2 20.6 21.6 4.4 4.9 5.2 5.7
Per-protocol analysisb 16.8 15.9 23.2 23.2 5.4 4.4 5.3 5.6
Atopic subgroup, ITT samplea 16.3 14.6 21.0 21.9 4.9 6.5 6.9 8.1
Atopic subgroup, per-protocol sampleb 21.7 17.7 24.9 24.0 5.3 6.8 6.6 9.4
aAll observations were analyzed according to the heater type exposure to which they were assigned. bThe analysis was limited to schools and days for which heater use was esti-
mated as ≥ 30%.
Table 6. Effect of heater type (unflued gas heater/flued gas heater) on symptoms. Table 6. continued.
Morning symptomsa Evening symptomsb Morning cough Evening cough Morning wheeze Evening wheeze Sore teeth Stomachache
Use of bronchodilators for relief 
of symptoms
Population ORc (95% CI) p-Value ORc (95% CI) p-Value ORc (95% CI) p-Value ORc (95% CI) p-Value OR (95% CI) p-Value OR (95% CI) p-Value OR (95% CI) p-Value OR (95% CI) p-Value OR (95% CI) p-Value
ITT analysisd 0.931 (0.810–1.071) 0.32 0.962 (0.859–1.076) 0.49 0.994 (0.850–1.162) 0.94 1.161 (1.008–1.336) 0.04 1.381 (1.041–1.832) 0.03 1.116 (0.856–1.454) 0.42 0.861 (0.630–1.179) 0.35 1.156 (0.894– 1.496) 0.27 0.870 (0.590–1.282) 0.48
Per-protocol analysise 0.737 (0.512–1.060) 0.10 0.888 (0.671–1.176) 0.41 0.872 (0.574–1.325) 0.52 1.192 (0.842 –1.686) 0.32 1.577 (0.640–3.888) 0.32 1.582 (0.714–3.507) 0.26 1.357 (0.584–3.149) 0.48 0.993 (0.513–1.923) 0.98 0.843 (0.273– 2.602) 0.77
ITT analysis, adjusted for home use 
of gas, open fire for heating, and 
exposure to ETSf
0.938 (0.801–1.098) 0.43 0.963 (0.852–1.089) 0.55 1.006 (0.844–1.200) 0.94 1.103 (0.949–1.283) 0.20 1.603 (1.171–2.194) 0.003 1.123 (0.856–1.473) 0.40 0.897 (0.644–1.249) 0.52 1.309 (0.997–1.718) 0.05 0.890 (0.596–1.329) 0.57
Atopic subgroup, ITT sampleg 0.805 (0.650–0.997) 0.05 0.920 (0.764–1.107) 0.38 0.769 (0.604–0.979) 0.03 1.156 (0.923–1.448) 0.21 1.849 (1.258–2.718) 0.002 1.144 (0.814–1.607) 0.44 0.846 (0.524–1.365) 0.49 1.627 (1.064–2.488) 0.02 1.868 (1.075–3.247) 0.03
Atopic subgroup, per-protocol sampleh 0.843 (0.498–1.427) 0.52 0.958 (0.594–1.544) 0.86 0.722 (0.399–1.306) 0.28 1.256 (0.718–2.197) 0.42 7.721 (1.551– 38.434) 0.01 3.968 (1.369–11.502) 0.01 1.427 (0.436–4.674) 0.56 1.311 (0.444– 3.867) 0.62 7.040 (0.945–52.442) 0.06
aReported either cough or wheeze in the morning. bReported cough, wheeze or chest tightness, fever, sore throat, runny or blocked nose, eye irritation, sore teeth or gums, or stom-
achache in the evening. cORs > 1 indicate that exposure to the unflued gas heater, compared with the flued gas heater, is associated with an increased risk of symptoms. The model 
used to estimate these ORs is described in “Methods.” dAll observations were analyzed according to the heater type exposure to which they were assigned. There were 9,079 obser-
vations for morning wheeze and 8,858 observations for evening wheeze. eThe analysis was limited to schools and days for which heater use was estimated as ≥ 30%. There were
1,668 observations for morning wheeze and 1,986 observations for evening wheeze. f ITT analysis adjusted for home use of gas heating, open fire, and exposure to ETS; all observations 
were analyzed according to the heater type exposure to which they were assigned. The additional time-variable covariates were included in the model. There were 7,179 observations 
for morning wheeze and 7,604 observations for evening wheeze. gITT analysis limited to subjects with atopy. There were 3,418 observations for morning wheeze and 3,320 observations 
for evening wheeze. hPer-protocol analysis limited to subjects with atopy. There were 596 observations for morning wheeze and 706 observations for evening wheeze.Health effects of low-NOx unflued gas heaters
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subgroup (p = 0.0008 for morning wheeze and 
p = 0.0001 for evening wheeze). No signifi-
cant estimated effects of heater type on wheeze 
scores were observed in the overall ITT or 
per-protocol analyses. However, in the atopic 
subgroup, there was a significantly increased 
wheeze score in the evening during exposure to 
the unflued gas heater in the ITT analysis (p = 
0.05), and this was more significant in the per-
protocol analysis in this subgroup (p = 0.02).
Number needed to treat. The absolute dif-
ference in daily prevalence of wheeze between 
when the low-NOx unflued gas heater was 
scheduled to operate and days when the flued 
gas heater was scheduled to operate was 0.5% 
(4.9% vs. 4.4%). This is equivalent to a num-
ber needed to harm of 200 (1/0.005). Hence, 
200 children need to be removed from expo-
sure to low-NOx unflued gas heaters during 
the 6-week period in which this study was 
conducted to prevent one child reporting 
wheeze in the morning on an average day.
Discussion
We have shown that in-class exposure 
to unflued gas heaters is associated with 
a) increased reporting of wheeze in the morn-
ing and possibly with increased cough and 
wheeze during the day (reported in the eve-
ning) and b) in children with current asthma, 
an increase in airway inflammation, manifest 
as eNO. However, exposure to unflued gas 
heaters was not associated with a significant 
reduction in lung function, whether measured 
at home or at school. In fact, there was a para-
doxical increase in evening PEF with exposure 
to unflued gas heaters when the analysis was 
restricted to days when heater use was ≥ 30% 
of school time and in subjects with asthma. 
The association of unflued gas heating with 
cough and wheeze was greatest in atopic (aller-
gic) subjects, who represented over half the 
study population. Atopic subjects were also 
more likely to use bronchodilator (reliever) 
medications during exposure to unflued gas 
heaters. We have also shown that mean NO2 
and formaldehyde levels were substantially 
increased in classrooms during the operation 
of unflued (compared with flued) gas heaters.
Strengths and limitations. The major 
strengths of this study design are the random-
ized crossover design, the blinding of partici-
pants and researchers to exposure allocation, 
the inclusion of items designed to detect infor-
mation bias, and the use of objective outcome 
measures. Taken together, these attributes give 
a high level of confidence that selection bias, 
confounding, and information bias have been 
avoided by design or would have been detected 
if present. The absence of consistent evidence 
of an adverse association with stomachache 
or sore teeth gives some confidence that the 
adverse effect on wheeze and cough was not 
attributable to information bias.
Another strength of the study is the high 
participation rate. This lends weight to the 
external validity of the study in relation to 
primary school children in NSW. The preva-
lence of asthma in this population (15.3%) is 
very close to the estimate for 9- to 15-year-olds 
in the recent NSW Health Survey (13.9%) 
(Centre for Epidemiology and Research 2010).
The main limitation of the study, as 
implemented, was the low usage of heaters 
during the study period, presumably because 
of the unseasonably warm weather in late 
August and early September. Temperature 
data for the three main towns in the study 
area are shown in Supplemental Material, 
Table E2 (doi:10.1289/ehp.1002186). This 
table shows that the temperatures increased 
toward the latter part of the study period. The 
lack of use of the heaters limited our capacity 
to assess their impact on children’s health.
Another limitation, which is inherent 
in this crossover study design, is inability to 
assess impacts on long-term health outcomes. 
Only short-term (acute) effects can be meas-
ured. However, studies designed to assess 
long-term effects are likely to have problems 
with selection bias and confounding, because 
it is not feasible to adopt a randomized design 
as we have in this study.
Discordance between lung function and 
symptom findings. The discordance between 
the symptom and lung function data was 
unexpected, although it is consistent with 
the findings of the two previous randomized 
controlled trials in this field (Howden-
Chapman et al. 2008; Pilotto et al. 2004). 
One possible explanation is that subjects with 
asthma used additional bronchodilators to 
relieve symptoms and that this resulted in 
an increase in their lung function at the time 
the measurements were made. The finding of 
increased reliever use in people with asthma 
tends to support this explanation.
An alternative explanation is that exposure 
to the unflued gas heater emissions results 
in sensory changes without effects on airway 
function. Indeed, there is evidence that NO2 
does have effects on sensory neuropeptides 
in the respiratory tract in an animal model 
(Lucchini et al. 1996).
Sensitive subgroups. There is evidence that 
NO2 exposure attributable to traffic is associ-
ated with an increase risk of wheezing illness 
in children (Pershagen et al. 1995; Peters et al. 
1999) and an increased risk of hospitalizations 
for asthma (Simpson et al. 2005). Hence, we 
expected that children with asthma would be 
more susceptible to the adverse effects of expo-
sure to unflued gas heaters. In fact, the find-
ings do not generally support this conclusion.
We did find that atopic status defined a 
large subgroup of the population who were 
more likely to report symptoms with exposure 
to unflued gas heaters. This is consistent with 
the observation that pre-exposure NO2 was 
associated with increased early and late asth-
matic response to house dust mite allergen chal-
lenge in sensitized subjects (Tunnicliffe et al. 
1994). However, in that study, this effect was 
seen only at high levels of exposure (400 ppb) 
and not at 100 ppb. There is also evidence from 
some epidemiological studies that the effects of 
exposure to gas appliance were more marked in 
atopic subjects (Corbo et al. 2001; Garrett et al. 
1998; Jarvis et al. 1996; Kerkhof et al. 1999), 
although others have not observed this result 
(Ponsonby et al. 2001b).
Conclusion
We conclude that, when compared with expo-
sure to flued gas heaters, classroom exposure 
to newer-style low-NOx unflued gas heaters 
increased respiratory symptoms, particularly 
Table 6. Effect of heater type (unflued gas heater/flued gas heater) on symptoms. Table 6. continued.
Morning symptomsa Evening symptomsb Morning cough Evening cough Morning wheeze Evening wheeze Sore teeth Stomachache
Use of bronchodilators for relief 
of symptoms
Population ORc (95% CI) p-Value ORc (95% CI) p-Value ORc (95% CI) p-Value ORc (95% CI) p-Value OR (95% CI) p-Value OR (95% CI) p-Value OR (95% CI) p-Value OR (95% CI) p-Value OR (95% CI) p-Value
ITT analysisd 0.931 (0.810–1.071) 0.32 0.962 (0.859–1.076) 0.49 0.994 (0.850–1.162) 0.94 1.161 (1.008–1.336) 0.04 1.381 (1.041–1.832) 0.03 1.116 (0.856–1.454) 0.42 0.861 (0.630–1.179) 0.35 1.156 (0.894– 1.496) 0.27 0.870 (0.590–1.282) 0.48
Per-protocol analysise 0.737 (0.512–1.060) 0.10 0.888 (0.671–1.176) 0.41 0.872 (0.574–1.325) 0.52 1.192 (0.842 –1.686) 0.32 1.577 (0.640–3.888) 0.32 1.582 (0.714–3.507) 0.26 1.357 (0.584–3.149) 0.48 0.993 (0.513–1.923) 0.98 0.843 (0.273– 2.602) 0.77
ITT analysis, adjusted for home use 
of gas, open fire for heating, and 
exposure to ETSf
0.938 (0.801–1.098) 0.43 0.963 (0.852–1.089) 0.55 1.006 (0.844–1.200) 0.94 1.103 (0.949–1.283) 0.20 1.603 (1.171–2.194) 0.003 1.123 (0.856–1.473) 0.40 0.897 (0.644–1.249) 0.52 1.309 (0.997–1.718) 0.05 0.890 (0.596–1.329) 0.57
Atopic subgroup, ITT sampleg 0.805 (0.650–0.997) 0.05 0.920 (0.764–1.107) 0.38 0.769 (0.604–0.979) 0.03 1.156 (0.923–1.448) 0.21 1.849 (1.258–2.718) 0.002 1.144 (0.814–1.607) 0.44 0.846 (0.524–1.365) 0.49 1.627 (1.064–2.488) 0.02 1.868 (1.075–3.247) 0.03
Atopic subgroup, per-protocol sampleh 0.843 (0.498–1.427) 0.52 0.958 (0.594–1.544) 0.86 0.722 (0.399–1.306) 0.28 1.256 (0.718–2.197) 0.42 7.721 (1.551– 38.434) 0.01 3.968 (1.369–11.502) 0.01 1.427 (0.436–4.674) 0.56 1.311 (0.444– 3.867) 0.62 7.040 (0.945–52.442) 0.06
aReported either cough or wheeze in the morning. bReported cough, wheeze or chest tightness, fever, sore throat, runny or blocked nose, eye irritation, sore teeth or gums, or stom-
achache in the evening. cORs > 1 indicate that exposure to the unflued gas heater, compared with the flued gas heater, is associated with an increased risk of symptoms. The model 
used to estimate these ORs is described in “Methods.” dAll observations were analyzed according to the heater type exposure to which they were assigned. There were 9,079 obser-
vations for morning wheeze and 8,858 observations for evening wheeze. eThe analysis was limited to schools and days for which heater use was estimated as ≥ 30%. There were
1,668 observations for morning wheeze and 1,986 observations for evening wheeze. f ITT analysis adjusted for home use of gas heating, open fire, and exposure to ETS; all observations 
were analyzed according to the heater type exposure to which they were assigned. The additional time-variable covariates were included in the model. There were 7,179 observations 
for morning wheeze and 7,604 observations for evening wheeze. gITT analysis limited to subjects with atopy. There were 3,418 observations for morning wheeze and 3,320 observations 
for evening wheeze. hPer-protocol analysis limited to subjects with atopy. There were 596 observations for morning wheeze and 706 observations for evening wheeze.Marks et al.
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in atopic children, but was not associated with 
measurable adverse changes in lung function. 
Although this latter finding reassures us that 
severe adverse consequences are unlikely in 
the short term, the increased burden of symp-
toms and the observation of higher levels of 
eNO with exposure to the unflued gas heater 
in the subgroup with asthma suggest an 
adverse effect that is best avoided. It is impor-
tant to seek alternative sources of domestic 
and public space heating that do not have 
adverse effects on health but are also effective 
and efficient for heating and have a favorable 
environmental profile.
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